DTCs can escape NK cell-mediated elimination through the expression of the wingless-related integration site (WNT) antagonist dickkopf WNT signaling pathway inhibitor 1 (DKK1), as demonstrated in lung adenocarcinoma and HER2-positive breast cancer mouse models (Malladi et al., 2016). This evidence concerns the gene ERBB2 and breast cancer.